Access

Article

Nature 402, 623-631 (9 December 1999) | doi:10.1038/45170; Received 18 August 1999; Accepted 20 October 1999

Open Innovation Challenges

  • Methods to Analyze Consumer Emotions

    • Deadline: Jan 17 2010
    • Reward: $10,000 USD

    The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

naturejobs

Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand

José Tormo1,2, Kannan Natarajan3, David H. Margulies3 & Roy A. Mariuzza1

  1. Center for Advanced Research in Biotechnology, University of Maryland Biotechnology Institute, 9,600 Gudelsky Drive, Rockville, Maryland 20850, USA
  2. Institut de Biologia Molecular de Barcelona, CSIC, Jordi Girona 18-26, 08034 Barcelona, Spain
  3. Molecular Biology Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA

Correspondence to: Correspondence and requests for materials should be addressed to R.A.M. (e-mail: Email: mariuzza@carb.nist.gov). or D.H.M. (e-mail: Email: dhm@nih.gov). Atomic coordinates have been deposited in the Protein Data Bank under accession number 1qo3.

Top

Natural killer (NK) cell function is regulated by NK receptors that interact with MHC class I (MHC-I) molecules on target cells. The murine NK receptor Ly49A inhibits NK cell activity by interacting with H-2Dd through its C-type-lectin-like NK receptor domain. Here we report the crystal structure of the complex between the Ly49A NK receptor domain and unglycosylated H-2Dd. The Ly49A dimer interacts extensively with two H-2Dd molecules at distinct sites. At one interface, a single Ly49A subunit contacts one side of the MHC-I peptide-binding platform, presenting an open cavity towards the conserved glycosylation site on the H-2Dd alpha2 domain. At a second, larger interface, the Ly49A dimer binds in a region overlapping the CD8-binding site. The smaller interface probably represents the interaction between Ly49A on the NK cell and MHC-I on the target cell, whereas the larger one suggests an interaction between Ly49A and MHC-I on the NK cell itself. Both Ly49A binding sites on MHC-I are spatially distinct from that of the T-cell receptor.